Discussion
acute leukaemia, blockOther leukaemia
AML, ACUTE LEUKAEMIA, LEUKAEMIA
The treatment of patients who have relapsed or refractory acute leukaemia with Because revumenib disrupts the effect of epigenetic regulators in leukaemia that are dependent on the menin–KMT2A interaction, this leads to abrogation of aberrant gene expression and removal of the haematopoietic differentiation blockOther leukaemia genotypes have recently been identified as susceptible to menin inhibition, such as AML with rearrangement of the nucleoporin 98 gene (In conclusion, in children and adults with highly refractory acute leukaemia with 